UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 632

Sortiert nach

Glycemic Control With Insulin Glargine Plus Insulin Glulisine Versus Premixed Insulin Analogues in Real-World Practices: A Cost-Effectiveness Study With a Randomized Pragmatic Trial Design

Clinical therapeutics, 2011-07, Vol.33 (7), p.841-850

2011

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research

Diabetes, metabolic syndrome and obesity, 2017, Vol.10, p.123-139

2017

Volltextzugriff (PDF)

A real‐world study of treatment patterns and outcomes in US managed‐care patients with type 2 Diabetes initiating injectable therapies

Diabetes, obesity & metabolism, 2017-03, Vol.19 (3), p.375-386

2017

Volltextzugriff (PDF)

Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes

Journal of managed care & specialty pharmacy, 2014-05, Vol.20 (5), p.501-512

2014

Volltextzugriff (PDF)

Practical combination therapy based on pathophysiology of type 2 diabetes

Diabetes, metabolic syndrome and obesity, 2016-01, Vol.9, p.355-369

Levin, Philip A

2016

Volltextzugriff (PDF)

Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes

Journal of managed care & specialty pharmacy, 2015-12, Vol.21 (12), p.1172

2015

Volltextzugriff (PDF)

Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting

Endocrine practice, 2018-09, Vol.24 (9), p.805-814

2018

Volltextzugriff (PDF)

Clinical outcomes using long-term combination therapy with insulin glargine and exenatide in patients with type 2 diabetes mellitus

Endocrine practice, 2012-01, Vol.18 (1), p.17-25

2012

Volltextzugriff (PDF)

Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin

BMJ open diabetes research & care, 2016-08, Vol.4 (1), p.e000228-e000228

2016

Volltextzugriff (PDF)

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

The journal of clinical endocrinology and metabolism, 2013-03, Vol.98 (3), p.1154-1162

2013

Volltextzugriff (PDF)

Extracorporal Membrane Oxygenation in Nonintubated Patients (Awake ECMO) With COVID-19 Adult Respiratory Distress Syndrome: The Israeli Experience

ASAIO journal (1992), 2023-08, Vol.69 (8), p.e363-e367

2023

Volltextzugriff (PDF)

Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial

Vascular health and risk management, 2010-01, Vol.6 (default), p.261-271

2010

Volltextzugriff (PDF)

Linogliride fumarate, representing a new class of oral hypoglycemic agent for diabetes

Clinical pharmacology and therapeutics, 1987-11, Vol.42 (5), p.498-503

1987

Volltextzugriff (PDF)

Benign parotid enlargement in bulimia

Annals of internal medicine, 1980-12, Vol.93 (6), p.827

1980

Volltextzugriff (PDF)

Growth hormone (GH) response to GH-releasing hormone in children with subnormal integrated concentrations of GH

The journal of clinical endocrinology and metabolism, 1986-06, Vol.62 (6), p.1110-1115

1986

Volltextzugriff (PDF)

Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression

The journal of clinical endocrinology and metabolism, 1981-07, Vol.53 (1), p.179-183

1981

Volltextzugriff (PDF)

Differential effects of adrenocorticotropin(1–24) on [ 3H]2-deoxy- d-glucose uptake in cultured cells derived from different brain regions

Neuroscience letters, 1988-10, Vol.93 (1), p.79-84

1988

Volltextzugriff (PDF)

434 ENHANCED RESPONSE TO hpGRH-40 IN GROWTH HORMONE NEUROSECRETORY DYSFUNCTION

Pediatric research, 1985-04, Vol.19 (4), p.183-183A

1985

Volltextzugriff (PDF)

Detection of Primary Aldosteronism by the 6-Hour Integrated Aldosterone/Renin Ratio

Hypertension (Dallas, Tex. 1979), 1986-04, Vol.8 (4, Part 1), p.285-289

1986

Volltextzugriff (PDF)

Diagnosis of reactive hypoglycemia: pitfalls in the use of the oral glucose tolerance test

Southern medical journal (Birmingham, Ala.), 1986-03, Vol.79 (3), p.285-287

1986

Volltextzugriff (PDF)

Diabetes Mellitus: Customizing Management

Hospital Practice, 1984-10, Vol.19 (10), p.137-149

1984

Volltextzugriff (PDF)

Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19

The New England journal of medicine, 2022-06, Vol.386 (23), p.2188-2200

2022

Volltextzugriff (PDF)

Communication Skills Training for Oncology Professionals

Journal of clinical oncology, 2012-04, Vol.30 (11), p.1242-1247

2012

Volltextzugriff (PDF)

Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease

Circulation (New York, N.Y.), 2021-08, Vol.144 (5), p.353-364

2021

Volltextzugriff (PDF)

Mild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery

Advanced materials (Weinheim), 2020-01, Vol.32 (1), p.e1904905-n/a

2020

Volltextzugriff (PDF)

1 – 25 von 632

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(548)
Mit Volltextzugriff
(528)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Glycemic Control With Insulin Glargine Plus Insulin Glulisine Versus Premixed Insulin Analogues in Real-World Practices: A Cost-Effectiveness Study With a Randomized Pragmatic Trial Design

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research

A real‐world study of treatment patterns and outcomes in US managed‐care patients with type 2 Diabetes initiating injectable therapies

Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes

Practical combination therapy based on pathophysiology of type 2 diabetes

Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes

Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting

Clinical outcomes using long-term combination therapy with insulin glargine and exenatide in patients with type 2 diabetes mellitus

Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled insulin

Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension

Extracorporal Membrane Oxygenation in Nonintubated Patients (Awake ECMO) With COVID-19 Adult Respiratory Distress Syndrome: The Israeli Experience

Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial

Linogliride fumarate, representing a new class of oral hypoglycemic agent for diabetes

Benign parotid enlargement in bulimia

Growth hormone (GH) response to GH-releasing hormone in children with subnormal integrated concentrations of GH

Daughters of women with breast cancer have elevated mean 24-hour prolactin (PRL) levels and a partial resistance of PRL to dopamine suppression

Differential effects of adrenocorticotropin(1–24) on [ 3H]2-deoxy- d-glucose uptake in cultured cells derived from different brain regions

434 ENHANCED RESPONSE TO hpGRH-40 IN GROWTH HORMONE NEUROSECRETORY DYSFUNCTION

Detection of Primary Aldosteronism by the 6-Hour Integrated Aldosterone/Renin Ratio

Diagnosis of reactive hypoglycemia: pitfalls in the use of the oral glucose tolerance test

Diabetes Mellitus: Customizing Management

Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19

Communication Skills Training for Oncology Professionals

Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease

Mild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery

Suchergebnisse filtern